glp-1 heart palpitations Palpitations: Safety, Causes & Management Understanding Ozempic and heart palpitations:

Individuals who are overweight or have a Body Mass Index (BMI) of 30 or higher, indicating obesity People with health issues such as diabetes, high blood pressure, or high cholesterol Those who are in the process of weight loss and require additional support Individuals seeking to reduce unhealthy snacking habits People who have not seen results from other weight-loss methods, such as non-standard weight loss medications Anyone looking for a safe weight-loss solution with no side effects or risk of yo-yo weight gain Who Should Not Use the GLP-1

BMI requirements for GLP-1 medications are based on obesity treatment guidelines, FDA-approved indications, and clinical trials evaluating safety and effectiveness

The recommended dosage of Ozempic for persons with type 2 diabetes is 0.25 mg once a week for the first 4 weeks, followed by increasing dosages over the coming months

Fontes-Dutra M, Santos-Terra J, Deckmann I, Brum Schwingel G, Della-Flora Nunes G, Hirsch MM, et al